Asset Allocation

As of January 31, 2026.
Type % Net
Cash 8.53%
Stock 60.27%
Bond 31.65%
Convertible 0.00%
Preferred 0.00%
Other -0.45%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2026
Large 82.66%
Mid 14.95%
Small 2.40%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 103.3%    % Emerging Markets: 0.69%    % Unidentified Markets: -3.97%

Americas 98.04%
97.24%
Canada 0.84%
United States 96.39%
0.80%
Colombia 0.13%
Mexico 0.56%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.52%
United Kingdom 0.74%
4.78%
Germany 0.21%
Ireland 2.97%
Netherlands 0.56%
Norway 0.11%
Spain 0.31%
Switzerland 0.18%
0.00%
0.00%
Greater Asia 0.40%
Japan 0.00%
0.00%
0.40%
Singapore 0.40%
0.00%
Unidentified Region -3.97%

Bond Credit Quality Exposure

AAA 10.12%
AA 44.59%
A 8.55%
BBB 24.80%
BB 3.00%
B 0.00%
Below B 0.17%
    CCC 0.17%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.26%
Not Available 8.52%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
28.61%
Materials
1.86%
Consumer Discretionary
11.98%
Financials
13.05%
Real Estate
1.72%
Sensitive
55.83%
Communication Services
11.07%
Energy
3.25%
Industrials
8.20%
Information Technology
33.31%
Defensive
15.56%
Consumer Staples
3.80%
Health Care
9.45%
Utilities
2.32%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 35.53%
Corporate 43.02%
Securitized 21.44%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
3.91%
Less than 1 Year
3.91%
Intermediate
46.26%
1 to 3 Years
7.89%
3 to 5 Years
15.03%
5 to 10 Years
23.34%
Long Term
49.83%
10 to 20 Years
11.46%
20 to 30 Years
33.01%
Over 30 Years
5.36%
Other
0.00%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial